comparemela.com
Home
Live Updates
XPhyto Therapeutics Corp.: XPhyto Completes Rotigotine Transdermal Patch Optimization and Comparative Skin Absorption Study : comparemela.com
XPhyto Therapeutics Corp.: XPhyto Completes Rotigotine Transdermal Patch Optimization and Comparative Skin Absorption Study
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a product development
Related Keywords
Germany ,
Biberach ,
Baden Wüberg ,
United States ,
Canada ,
Uttenweiler ,
Vancouver ,
British Columbia ,
America ,
Canadian ,
German ,
Hugh Rogers ,
Xphyto Rotigotine ,
Xphyto Therapeutics Corp ,
Wissen Market Research ,
Company Rotigotine ,
Kuick Research ,
Precedence Research ,
Vektor Pharma ,
North America ,
Market Regulator ,
Xphyto ,
Herapeutics ,
Orp ,
Ompletes ,
Otigotine ,
Transdermal ,
Watch ,
Ptimization ,
Comparative ,
Skin ,
Absorption ,
Study ,
comparemela.com © 2020. All Rights Reserved.